Cadila Healthcare jumps 5% on receiving nod for human trials of Covid-19 drug

The approval process was fast-tracked, following recommendation by the subject expert committee and considering the emergency and unmet medical need during the pandemic.

from Stocks-Markets-Economic Times https://ift.tt/31EppXu